Sheng Mao Hospital launched a "3.5 generation AI artificial intelligence test tube technology" this year, which can increase the pregnancy rate by nearly 80%, which is three times higher than that of ordinary embryos. (Photo courtesy of Sheng Mao Hospital) An opportunity for elderly women: 3.5 generation AI artificial intelligence test tube technology
This year, Sheng Mao Hospital conducted the research on "3.5 generation AI artificial intelligence test tube technology". The results show that the pregnancy rate of artificial test-tube embryos selected by this technology can be improved by nearly 80%, which is obviously ahead of the general pregnancy rate of 30% to 50%. The abortion rate has also dropped from an average of 20% to 5%; Moreover, the pregnancy rate of good embryos is three times higher than that of ordinary embryos.
This research paper, written by Li Junyi, CEO of Sheng Mao Hospital, has been highly praised by international reproductive medicine professors and experts, which can be said to win honor for Taiwan. The big data generated by such high-end technology is being continuously studied in cooperation with Academia Sinica and third-party manufacturers. Sheng Mao Hospital will apply for a world patent to protect Taiwan Province's intellectual property rights in artificial reproductive medicine.
The research paper verifies that the pregnancy rate of the selected embryos is three times that of the general embryos, and the pregnancy rate is as high as 80%.
CEO Li Junyi explained that the research object was 107 women under the age of 38. The "3.5 generation AI artificial intelligence test tube technology" was adopted, and the traditional chip detection method was replaced by the "Preimplantation Gene Screening (PGS)" and the next generation sequencing analysis (NGS) technology platform to screen out abnormal chromosomes and eliminate them.